Skip to main content
Advertisement
  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Education
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Online Sections
    • Neurology Video Journal Club
    • Diversity, Equity, & Inclusion (DEI)
    • Neurology: Clinical Practice Accelerator
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • COVID-19
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Neurology Future Forecasting Series
    • Null Hypothesis
    • Patient Pages
    • Topics A-Z
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit New Manuscript
    • Submit Revised Manuscript
    • Author Center

Advanced Search

Main menu

  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Education
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Online Sections
    • Neurology Video Journal Club
    • Diversity, Equity, & Inclusion (DEI)
    • Neurology: Clinical Practice Accelerator
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • COVID-19
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Neurology Future Forecasting Series
    • Null Hypothesis
    • Patient Pages
    • Topics A-Z
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit New Manuscript
    • Submit Revised Manuscript
    • Author Center
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Neurology Video Journal Club
  • Residents & Fellows

User menu

  • Subscribe
  • My Alerts
  • Log in

Search

  • Advanced search
Neurology
Home
The most widely read and highly cited peer-reviewed neurology journal
  • Subscribe
  • My Alerts
  • Log in
Site Logo
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Neurology Video Journal Club
  • Residents & Fellows

Share

July 17, 2012; 79 (3) Articles

Low PiB PET retention in presence of pathologic CSF biomarkers in Arctic APP mutation carriers

Michael Schöll, Anders Wall, Steinunn Thordardottir, Daniel Ferreira, Nenad Bogdanovic, Bengt Långström, Ove Almkvist, Caroline Graff, Agneta Nordberg
First published June 13, 2012, DOI: https://doi.org/10.1212/WNL.0b013e31825fdf18
Michael Schöll
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anders Wall
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Steinunn Thordardottir
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Daniel Ferreira
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nenad Bogdanovic
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bengt Långström
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ove Almkvist
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Caroline Graff
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Agneta Nordberg
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Full PDF
Citation
Low PiB PET retention in presence of pathologic CSF biomarkers in Arctic APP mutation carriers
Michael Schöll, Anders Wall, Steinunn Thordardottir, Daniel Ferreira, Nenad Bogdanovic, Bengt Långström, Ove Almkvist, Caroline Graff, Agneta Nordberg
Neurology Jul 2012, 79 (3) 229-236; DOI: 10.1212/WNL.0b013e31825fdf18

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Permissions

Make Comment

See Comments

Downloads
390

Share

  • Article
  • Figures & Data
  • Info & Disclosures
Loading

Article Information

vol. 79 no. 3 229-236
DOI: 
https://doi.org/10.1212/WNL.0b013e31825fdf18
PubMed: 
22700814

Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
0028-3878
Online ISSN: 
1526-632X
History: 
  • Received September 2, 2011
  • Accepted December 1, 2011
  • First Published June 13, 2012.

Article Versions

  • Previous version (June 13, 2012 - 13:01).
  • You are viewing the most recent version of this article.
Copyright & Usage: 
Copyright © 2012 by AAN Enterprises, Inc.

Author Disclosures

    1. Michael Schöll, PhD,
    2. Anders Wall, PhD,
    3. Steinunn Thordardottir, MD,
    4. Daniel Ferreira, MSc,
    5. Nenad Bogdanovic, MD, PhD,
    6. Bengt Långström, PhD,
    7. Ove Almkvist, PhD,
    8. Caroline Graff, MD, PhD and
    9. Agneta Nordberg, MD, PhD
  1. Michael Schöll, PhD,
  2. Scientific Advisory Boards:
    1. NONE

    Gifts:
    1. NONE

    Funding for Travel or Speaker Honoraria:
    1. NONE

    Editorial Boards:
    1. NONE

    Patents:
    1. NONE

    Publishing Royalties:
    1. NONE

    Employment, Commercial Entity:
    1. NONE

    Consultancies:
    1. NONE

    Speakers’ Bureaus:
    1. NONE

    Other Activities:
    1. NONE

    Clinical Procedures or Imaging Studies:
    1. NONE

    Research Support, Commercial Entities:
    1. NONE

    Research Support, Government Entities:
    1. NONE

    Research Support, Academic Entities:
    1. NONE

    Research Support, Foundations and Societies:
    1. Gun and Bertil Stohne’s foundation; The Old Servants foundation; The Sigurd and Elsa Goljes foundation

    Stock/Stock Options/Board of Directors Compensation:
    1. NONE

    License Fee Payments, Technology or Inventions:
    1. NONE

    Royalty Payments, Technology or Inventions:
    1. NONE

    Stock/Stock Options, Research Sponsor:
    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:
    1. NONE

    Legal Proceedings:
    1. NONE

  3. Anders Wall, PhD,
  4. Scientific Advisory Boards:
    1. NONE

    Gifts:
    1. NONE

    Funding for Travel or Speaker Honoraria:
    1. NONE

    Editorial Boards:
    1. NONE

    Patents:
    1. NONE

    Publishing Royalties:
    1. NONE

    Employment, Commercial Entity:
    1. Employee at PET-center, Uppsala univeristy hostpital, Uppsala, Sweden

    Consultancies:
    1. NONE

    Speakers’ Bureaus:
    1. NONE

    Other Activities:
    1. NONE

    Clinical Procedures or Imaging Studies:
    1. NONE

    Research Support, Commercial Entities:
    1. NONE

    Research Support, Government Entities:
    1. NONE

    Research Support, Academic Entities:
    1. NONE

    Research Support, Foundations and Societies:
    1. NONE

    Stock/Stock Options/Board of Directors Compensation:
    1. NONE

    License Fee Payments, Technology or Inventions:
    1. NONE

    Royalty Payments, Technology or Inventions:
    1. NONE

    Stock/Stock Options, Research Sponsor:
    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:
    1. NONE

    Legal Proceedings:
    1. NONE

  5. Steinunn Thordardottir, MD,
  6. Scientific Advisory Boards:
    1. NONE

    Gifts:
    1. NONE

    Funding for Travel or Speaker Honoraria:
    1. NONE

    Editorial Boards:
    1. NONE

    Patents:
    1. NONE

    Publishing Royalties:
    1. NONE

    Employment, Commercial Entity:
    1. NONE

    Consultancies:
    1. NONE

    Speakers’ Bureaus:
    1. NONE

    Other Activities:
    1. NONE

    Clinical Procedures or Imaging Studies:
    1. NONE

    Research Support, Commercial Entities:
    1. NONE

    Research Support, Government Entities:
    1. NONE

    Research Support, Academic Entities:
    1. NONE

    Research Support, Foundations and Societies:
    1. NONE

    Stock/Stock Options/Board of Directors Compensation:
    1. NONE

    License Fee Payments, Technology or Inventions:
    1. NONE

    Royalty Payments, Technology or Inventions:
    1. NONE

    Stock/Stock Options, Research Sponsor:
    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:
    1. NONE

    Legal Proceedings:
    1. NONE

  7. Daniel Ferreira, MSc,
  8. Scientific Advisory Boards:
    1. NONE

    Gifts:
    1. NONE

    Funding for Travel or Speaker Honoraria:
    1. NONE

    Editorial Boards:
    1. NONE

    Patents:
    1. NONE

    Publishing Royalties:
    1. NONE

    Employment, Commercial Entity:
    1. NONE

    Consultancies:
    1. NONE

    Speakers’ Bureaus:
    1. NONE

    Other Activities:
    1. NONE

    Clinical Procedures or Imaging Studies:
    1. NONE

    Research Support, Commercial Entities:
    1. NONE

    Research Support, Government Entities:
    1. FPI grant (MICINN, Spain). Grant number: BES-2007-15658

    Research Support, Academic Entities:
    1. NONE

    Research Support, Foundations and Societies:
    1. NONE

    Stock/Stock Options/Board of Directors Compensation:
    1. NONE

    License Fee Payments, Technology or Inventions:
    1. NONE

    Royalty Payments, Technology or Inventions:
    1. NONE

    Stock/Stock Options, Research Sponsor:
    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:
    1. NONE

    Legal Proceedings:
    1. NONE

  9. Nenad Bogdanovic, MD, PhD,
  10. Scientific Advisory Boards:
    1. NONE

    Gifts:
    1. NONE

    Funding for Travel or Speaker Honoraria:
    1. NONE

    Editorial Boards:
    1. NONE

    Patents:
    1. NONE

    Publishing Royalties:
    1. NONE

    Employment, Commercial Entity:
    1. NONE

    Consultancies:
    1. NONE

    Speakers’ Bureaus:
    1. NONE

    Other Activities:
    1. NONE

    Clinical Procedures or Imaging Studies:
    1. NONE

    Research Support, Commercial Entities:
    1. NONE

    Research Support, Government Entities:
    1. NONE

    Research Support, Academic Entities:
    1. NONE

    Research Support, Foundations and Societies:
    1. NONE

    Stock/Stock Options/Board of Directors Compensation:
    1. NONE

    License Fee Payments, Technology or Inventions:
    1. NONE

    Royalty Payments, Technology or Inventions:
    1. NONE

    Stock/Stock Options, Research Sponsor:
    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:
    1. NONE

    Legal Proceedings:
    1. NONE

  11. Bengt Långström, PhD,
  12. Scientific Advisory Boards:
    1. NONE

    Gifts:
    1. NONE

    Funding for Travel or Speaker Honoraria:
    1. NONE

    Editorial Boards:
    1. Journal of labelled Compounds and Radiopharmaceuticals

    Patents:
    1. NONE

    Publishing Royalties:
    1. NONE

    Employment, Commercial Entity:
    1. NONE

    Consultancies:
    1. NONE

    Speakers’ Bureaus:
    1. NONE

    Other Activities:
    1. NONE

    Clinical Procedures or Imaging Studies:
    1. NONE

    Research Support, Commercial Entities:
    1. NONE

    Research Support, Government Entities:
    1. NONE

    Research Support, Academic Entities:
    1. NONE

    Research Support, Foundations and Societies:
    1. NONE

    Stock/Stock Options/Board of Directors Compensation:
    1. NONE

    License Fee Payments, Technology or Inventions:
    1. NONE

    Royalty Payments, Technology or Inventions:
    1. NONE

    Stock/Stock Options, Research Sponsor:
    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:
    1. NONE

    Legal Proceedings:
    1. NONE

  13. Ove Almkvist, PhD,
  14. Scientific Advisory Boards:
    1. NONE

    Gifts:
    1. NONE

    Funding for Travel or Speaker Honoraria:
    1. NONE

    Editorial Boards:
    1. NONE

    Patents:
    1. NONE

    Publishing Royalties:
    1. NONE

    Employment, Commercial Entity:
    1. NONE

    Consultancies:
    1. NONE

    Speakers’ Bureaus:
    1. NONE

    Other Activities:
    1. NONE

    Clinical Procedures or Imaging Studies:
    1. NONE

    Research Support, Commercial Entities:
    1. NONE

    Research Support, Government Entities:
    1. NONE

    Research Support, Academic Entities:
    1. NONE

    Research Support, Foundations and Societies:
    1. NONE

    Stock/Stock Options/Board of Directors Compensation:
    1. NONE

    License Fee Payments, Technology or Inventions:
    1. NONE

    Royalty Payments, Technology or Inventions:
    1. NONE

    Stock/Stock Options, Research Sponsor:
    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:
    1. NONE

    Legal Proceedings:
    1. NONE

  15. Caroline Graff, MD, PhD and
  16. Scientific Advisory Boards:
    1. NONE

    Gifts:
    1. NONE

    Funding for Travel or Speaker Honoraria:
    1. Invited speaker at the Lundbecks Alzheimer symposium in Copenhagen, Denmark on “Molecular and genetic aspects of current Alzheimer research- Where are we heading?” November 5th 2009. Invited speaker on “Alzheimer’s disease and genetic counseling” at the National Dementia Days for staff in health care, in Örebro, 2010, May 19th, Sweden. Invited speaker on “Alzheimer’s disease and genetic counseling” at the National Dementia Sympoisum in Oslo, Norway 2010October 8th for clinicians and researchers in Norway.

    Editorial Boards:
    1. NONE

    Patents:
    1. Nr: JP2005-044776 and Nr: JP2010-48067 Issued in Japan. Diagnostik tool for dementia based on gene expression in fibroblasts.

    Publishing Royalties:
    1. NONE

    Employment, Commercial Entity:
    1. NONE

    Consultancies:
    1. NONE

    Speakers’ Bureaus:
    1. NONE

    Other Activities:
    1. NONE

    Clinical Procedures or Imaging Studies:
    1. NONE

    Research Support, Commercial Entities:
    1. NONE

    Research Support, Government Entities:
    1. YearFunding Agency 2011-2013Swedish Research Council, no. 21738 research grant

    Research Support, Academic Entities:
    1. YearFunding Agencyrole 2011-2014KID PhD-student funding, KIresearch grant 2006-2011KID PhD-student funding, KI research grant

    Research Support, Foundations and Societies:
    1. YearFunding Agencyrole 2005-2010Swedish Brain Power research grant 2010-2012Swedish Brain Powerresearch grant 2007-2010ALF-project Stockholm County Council research grant, mainly salary support 2006-2011KID PhD-student funding, KI salary funding 2009-2011Marianne and Marcus Wallenbergresearch grant and 3 years for my salary (75%) 2007-2011Other; Stohnes, Gamla tjänarinnor, Alzheimer Fondenresearch grants 2010-2012Postdoc funding from Roche, Geneva Salary support 2010-2011King Gustaf V and Queen Victorias Free masons foundation:500 research grant 2011-2013ALF-project Stockholm County Council research grant, mainly salary support

    Stock/Stock Options/Board of Directors Compensation:
    1. NONE

    License Fee Payments, Technology or Inventions:
    1. NONE

    Royalty Payments, Technology or Inventions:
    1. NONE

    Stock/Stock Options, Research Sponsor:
    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:
    1. NONE

    Legal Proceedings:
    1. NONE

  17. Agneta Nordberg, MD, PhD
  18. Scientific Advisory Boards:
    1. Elan Merck GE Healthcare Lundbeck AB Pfizer

    Gifts:
    1. NONE

    Funding for Travel or Speaker Honoraria:
    1. Novartis Merz Bayer Pfizer JansenCilag

    Editorial Boards:
    1. Journal Alzheimer Research advisory board memember Alzheimer Disease and Therapy advisory board member Current Alzheimer Research advisory board member

    Patents:
    1. NONE

    Publishing Royalties:
    1. NONE

    Employment, Commercial Entity:
    1. NONE

    Consultancies:
    1. NONE

    Speakers’ Bureaus:
    1. NONE

    Other Activities:
    1. NONE

    Clinical Procedures or Imaging Studies:
    1. NONE

    Research Support, Commercial Entities:
    1. Novaris GE Healthcare

    Research Support, Government Entities:
    1. Swedish Research Council

    Research Support, Academic Entities:
    1. NONE

    Research Support, Foundations and Societies:
    1. Knut and Alice Wallenberg foundation Swedish Brain foundation KI Strategic program Brain foundation Swedish Alzheimer foundation Stohnes foundation

    Stock/Stock Options/Board of Directors Compensation:
    1. NONE

    License Fee Payments, Technology or Inventions:
    1. NONE

    Royalty Payments, Technology or Inventions:
    1. NONE

    Stock/Stock Options, Research Sponsor:
    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:
    1. NONE

    Legal Proceedings:
    1. NONE

  1. From the Department of Neurobiology, Care Sciences, and Society (M.S., S.T., D.F., N.B., O.A., C.G., A.N.), Karolinska Institutet, Stockholm; PET Center, Section of Nuclear Medicine & PET, Department of Radiology, Oncology and Radiation Sciences (A.W.), and Department of Biochemistry and Organic Chemistry (B.L.), Uppsala University, Uppsala; Department of Geriatric Medicine (S.T., C.G., A.N.), Karolinska University Hospital Huddinge, Stockholm; and Department of Psychology (O.A.), Stockholm University, Stockholm, Sweden.
  1. Correspondence & reprint requests to Dr. Nordberg: agneta.k.nordberg{at}ki.se
View Full Text

Article usage

Article usage: June 2012 to May 2023

AbstractFullPdfSource
Jun 2012441043Highwire
Jul 201211182244Highwire
Aug 20122392126Highwire
Sep 2012117711Highwire
Oct 2012831012Highwire
Nov 20125188Highwire
Dec 20126135Highwire
Jan 20137074Highwire
Feb 20134556Highwire
Mar 20134271Highwire
Apr 20133932Highwire
May 20134346Highwire
Jun 20133447Highwire
Jul 20132835Highwire
Aug 20132313Highwire
Sep 20133132Highwire
Oct 20134773Highwire
Nov 20132845Highwire
Dec 20131921Highwire
Jan 20141100Highwire
Feb 20143225Highwire
Mar 20142510Highwire
Apr 20143954Highwire
May 20142013Highwire
Jun 20143031Highwire
Jul 20145274Highwire
Aug 20143565Highwire
Sep 20141810Highwire
Oct 20144100Highwire
Nov 20144821Highwire
Dec 20141812Highwire
Jan 20152321Highwire
Feb 20152211Highwire
Mar 20152411Highwire
Apr 20152922Highwire
May 20152101Highwire
Jun 20152211Highwire
Jul 20151910Highwire
Aug 20153031Highwire
Sep 20152571Highwire
Oct 20153031Highwire
Nov 20152411Highwire
Dec 20151440Highwire
Jan 20162410Highwire
Feb 20163711Highwire
Mar 20161850Highwire
Apr 20161343Highwire
May 2016732Highwire
Jun 20161500Highwire
Jul 20161912Highwire
Aug 20161310Highwire
Sep 20162424Highwire
Oct 20162011Highwire
Nov 20162100Highwire
Dec 20161511Highwire
Jan 20171500Highwire
Feb 2017811Highwire
Mar 2017920Highwire
Apr 20171511Highwire
May 2017600Highwire
Jun 2017911Highwire
Jul 2017242Highwire
Aug 2017830Highwire
Sep 2017611Highwire
Oct 2017842Highwire
Nov 20171222Highwire
Dec 20172300Highwire
Jan 20183343Highwire
Feb 20182231Highwire
Mar 20182635Highwire
Apr 20181923Highwire
May 20181112Highwire
Jun 20182900Highwire
Jul 20183653Highwire
Aug 20182450Highwire
Sep 20181622Highwire
Oct 20182163Highwire
Nov 20182343Highwire
Dec 20181710Highwire
Jan 20194041Highwire
Feb 20194522Highwire
Mar 20192422Highwire
Apr 20193543Highwire
May 20193223Highwire
Jun 20192711Highwire
Jul 20192511Highwire
Aug 20192831Highwire
Sep 20192643Highwire
Oct 20193321Highwire
Nov 20193311Highwire
Dec 20191533Highwire
Jan 20202912Highwire
Feb 20202032Highwire
Mar 20201601Highwire
Apr 20201421Highwire
May 20202521Highwire
Jun 20204700Highwire
Jul 20203811Highwire
Aug 20202501Highwire
Sep 20201700Highwire
Oct 20202182Highwire
Nov 20204110Highwire
Dec 20202911Highwire
Jan 20212742Highwire
Feb 20211762Highwire
Mar 20212510Highwire
Apr 20213751Highwire
May 20212500Highwire
Jun 20212454Highwire
Jul 20214133Highwire
Aug 20212511Highwire
Sep 20213105Highwire
Oct 20212996Highwire
Nov 20214301Highwire
Dec 20213311Highwire
Jan 20223601Highwire
Feb 20226374Highwire
Mar 20225923Highwire
Apr 20222720Highwire
May 20225862Highwire
Jun 20225933Highwire
Jul 20222222Highwire
Aug 20224075Highwire
Sep 20226482Highwire
Oct 20221381213Highwire
Nov 202210620Highwire
Dec 20226162Highwire
Jan 20234522Highwire
Feb 20233783Highwire
Mar 20235555Highwire
Apr 20233034Highwire
May 20234310Highwire

Cited By...

  • 115 Citations
  • Google Scholar

Letters: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
  • Article
    • Abstract
    • GLOSSARY
    • METHODS
    • RESULTS
    • DISCUSSION
    • AUTHOR CONTRIBUTIONS
    • DISCLOSURE
    • ACKNOWLEDGMENT
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Info & Disclosures
Advertisement

Effect of Atogepant for Preventive Migraine Treatment on Patient-Reported Outcomes in the Randomized, Double-blind, Phase 3 ADVANCE Trial

Dr. Jessica Ailani and Dr. Ailna Masters-Israilov

► Watch

Related Articles

  • The exception makes the ruleNot all Aβ plaques are created equal
  • Spotlight on the November 20 Issue

Topics Discussed

  • Alzheimer's disease
  • Cerebrospinal Fluid
  • MRI
  • PET

Alert Me

  • Alert me when eletters are published

Recommended articles

  • Articles
    APOE modifies the association between Aβ load and cognition in cognitively normal older adults
    K. Kantarci, V. Lowe, S.A. Przybelski et al.
    Neurology, December 21, 2011
  • Article
    Amyloid is linked to cognitive decline in patients with Parkinson disease without dementia
    Stephen N. Gomperts, Joseph J. Locascio, Dorene Rentz et al.
    Neurology, December 12, 2012
  • Articles
    Conversion of amyloid positive and negative MCI to AD over 3 years
    An 11C-PIB PET study

    A. Okello, J. Koivunen, P. Edison et al.
    Neurology, July 08, 2009
  • Articles
    Plasma Aβ and PET PiB binding are inversely related in mild cognitive impairment
    D.P. Devanand, N. Schupf, Y. Stern et al.
    Neurology, June 29, 2011
Neurology: 100 (23)

Articles

  • Ahead of Print
  • Current Issue
  • Past Issues
  • Popular Articles
  • Translations

About

  • About the Journals
  • Ethics Policies
  • Editors & Editorial Board
  • Contact Us
  • Advertise

Submit

  • Author Center
  • Submit a Manuscript
  • Information for Reviewers
  • AAN Guidelines
  • Permissions

Subscribers

  • Subscribe
  • Activate a Subscription
  • Sign up for eAlerts
  • RSS Feed
Site Logo
  • Visit neurology Template on Facebook
  • Follow neurology Template on Twitter
  • Visit Neurology on YouTube
  • Neurology
  • Neurology: Clinical Practice
  • Neurology: Education
  • Neurology: Genetics
  • Neurology: Neuroimmunology & Neuroinflammation
  • AAN.com
  • AANnews
  • Continuum
  • Brain & Life
  • Neurology Today

Wolters Kluwer Logo

Neurology | Print ISSN:0028-3878
Online ISSN:1526-632X

© 2023 American Academy of Neurology

  • Privacy Policy
  • Feedback
  • Advertise